Literature Analysis of 40 Cases of Adverse Drug Reactions of Nonprescription Chinese Patent Medicines for Diseases of Throat Department

Abstract

Abstract: ObjectiveTo analyze the occurrence of adverse drug reactions of nonprescription Chinese patent medicines which commonly used in diseases of throat department, in order to provide a reference for the safe use of such medicines. MethodsUsing a retrospective study method, the related literatures in CNKI were searched, collected and analyzed. ResultsThere were 14 varieties of nonprescription Chinese patent medicines involved, in which adverse reactions caused by andrographis tablet and compound Caoshanhu tablet were more than others. ConclusionThe safe use of nonprescription Chinese patent medicines still needs to be highly concerned.

Key words: nonprescription drugs, Chinese patent medicines, adverse reactions, diseases of throat department

CLC Number:

R994.11

WANG Pei-jie, WANG Jia-lun, YI Zhi-wei, Dong Yan-fei, WANG Pu. Literature Analysis of 40 Cases of Adverse Drug Reactions of Nonprescription Chinese Patent Medicines for Diseases of Throat Department[J]. Chinese Journal of Pharmacovigilance, 2015, 12(11): 690-692.

[1]	ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222.
[2]	GAO Yunjuan, ZHAO Xu, BAI Tiankai, BAI Zhaofang, WANG Jiabo, SONG Haibo, XIAO Xiaohe. Discovery and identification strategy for drug safety risks based on big data monitoring of adverse reactions [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 1-5.
[3]	ZOU Dongmei, FANG Fang, GUO Yixian, NI Jing, ZHAO Hong, HU Ronghua, SUN Wanling. Analysis of the association of adverse reactions with relative dose of melphalan and body weight in POEMS syndrome patients undergoing melphalan-based ASCT [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 911-914.
[4]	JIAO Fuzhi, CHEN Yarui, JI Wei, HAO Jianpeng, GUAN Quanlin. Short-term efficacy and safety evaluation of PD-1 inhibitor combined with chemotherapy as a first-line neoadjuvant therapy for locally advanced gastric adenocarcinoma [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 301-305.
[5]	LIU Zhike, ZHAN Siyan. Progress in applications of self-controlled designs in association study of vaccine safety [J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 74-78.
[6]	CUI Can, WEI Hongtao, CHENG Sheng, SHEN Su. Adverse reactions induced by teriparatide [J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 333-335.
[7]	LIU Min, PEI Xiaojing, WANG Haixue. Problems with and suggestions about expedited reporting of suspected unexpected serious adverse reactions during clinical trials of drugs in China [J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 176-179.
[8]	WU Chen, LIU Cuili, WANG Tao. Cardiovascular safety of haloperidol preparations [J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1100-1102.
[9]	QING Xiaoyan, ZENG Xiaomei. Hemoptysis and Arrhythmia Induced by Apatinib: A Case Report [J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 890-893.
[10]	CHANG Bingqing, GUO Yixian, ZHAO Hong, LAN Xiaoxi, SU Li, SUN Wanling. Adverse Reactions of Ultra-low Dose Decitabine in Elderly Patients with Intermediate- to high- risk Myelodysplastic Syndromes [J]. Chinese Journal of Pharmacovigilance, 2021, 18(8): 776-779.
[11]	XIE Yan, BIAN Yuan, DU Shan. Analysis of One Case of Severe Liver Injury Induced by Xinyuan Capsule [J]. Chinese Journal of Pharmacovigilance, 2021, 18(4): 361-364.
[12]	DAI Hui, LI Ming, DUANMU Yantao, WANG Fudong, PENG Dongming, YUAN Xiuju, LUO Juan. Clinical Application and Adverse Reactions of Lithium Carbonate in Anti-mania [J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 294-299.
[13]	ZHU Dongchun, SUN Xuqun, JIANG Haifeng, WANG Yushan, FANG Xianjun, XIA Quan. Analysis of 48 Cases of Drug Eruptions Induced by Amoxicillin [J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 583-588.
[14]	WEN Xiaoling, ZHANG Hailang. Literature Analysis of Adverse Reactions Caused by Polyene Phosphatidyl Choline [J]. Chinese Journal of Pharmacovigilance, 2020, 17(8): 526-530.
[15]	WANG Di, ZHANG Yongkai, LI Nan, LI Yanjiao. Literature Review of Adverse Skin Reactions Induced by Clopidogrel [J]. Chinese Journal of Pharmacovigilance, 2020, 17(8): 531-534.

Literature Analysis of 40 Cases of Adverse Drug Reactions of Nonprescription Chinese Patent Medicines for Diseases of Throat Department

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics